Clinical Trial Update: Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial update on IDP-122 for plaque psoriasis reports completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IDP-122

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2020-01-27